MCL Clinical Trials

15 clinical trials for MCL across international registries, including 7 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• A Study to Investigate the Safety of Novel Dose Ramp-up Schedule(s) When Initiating Sonrotoclax in Participants Treated for Blood Cancers. — RECRUITING · PHASE1
• Phase 2 Study of BTKi-Rituximab Induction Followed by Glofitamab Consolidation in High Risk Untreated MCL Patients - WINDOW-4 Study — RECRUITING · PHASE2
• Multicenter, Single-Arm Exploratory Phase I Clinical Study (Assessment of Safety and Efficacy) of Fully Human BAFF-R Chimeric Antigen Receptor T-Cell Injection in Relapsed/Refractory BAFF-R-Positive B-Cell Lymphoma — RECRUITING · PHASE1
• Glofitamab Combined With Lenalidomide in High Risk Patients With Relapsed or Refractory Mantle Cell Lymphoma — RECRUITING · PHASE2
• Fourth-gen CAR T Cells Targeting CD19/CD22 for Highly Resistant B-cell Lymphoma/Leukemia (PMBCL/CNS-BCL). — RECRUITING · PHASE1
• Sonrotoclax, Zanubrutinib and CD20mab in Untreated MCL Patients — RECRUITING · PHASE2
• Real-world Study of Acalabrutinib — RECRUITING
• First-in-Human (FIH) Trial in Patients With Relapsed, Progressive or Refractory B-Cell Lymphoma — ACTIVE_NOT_RECRUITING · PHASE1
• A Study of Glofitamab and Lenalidomide in People With Mantle Cell Lymphoma — ACTIVE_NOT_RECRUITING · PHASE1
• A Study of Tafasitamab and Lenalidomide in People With Mantle Cell Lymphoma — TERMINATED · PHASE2
• Study of TG-1801 Alone or in Combination With Ublituximab in Subjects With B-Cell Lymphoma or Chronic Lymphocytic Leukemia — TERMINATED · PHASE1
• Acalabrutinib and Rituximab in Elderly Patients With Untreated Mantle Cell Lymphoma — ACTIVE_NOT_RECRUITING · PHASE2
• HMPL-760 Safety and Tolerability Study in Patients With Previously Treated CLL/SLL or NHL — WITHDRAWN · PHASE1
• Multiparametric Cardiac MRI in Patients Under CAR T-cell Therapy — OTHER
• Peptide Receptor Radionuclide Therapy With 90Y-Dotatoc in Relapsed/Refractory Diffuse Large B Cell and Mantle Cell Lymphomas — TERMINATED · PHASE2

Refine this search